Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Lower zinc levels are linked to more severe hair loss in alopecia areata.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

Lasers and light therapy are effective for treating skin conditions like hair loss, vitiligo, psoriasis, and molluscum contagiosum.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

The M-type is the most common form of male hair loss, and the BASP-classification is easy for different medical professionals to use.

CAG repeat numbers in the AR gene likely don't affect hair loss in Korean men.

Msx2 deficiency in mice leads to bone growth and organ development problems.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

A new tool simplifies alopecia areata severity scoring but needs validation.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

A new model uses specific blood markers to predict if children's hair loss will return.

Certain gene variations and low adiponectin levels may increase the risk of hair loss in Egyptians.

Family history and elevated DHEA-S levels are linked to more severe hair loss.

Hyperandrogenism in women often causes acne and excess hair, treatable with personalized plans including weight loss, hair removal, and medications.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Microneedling, especially with drugs, effectively treats hair loss.

People with Alopecia Areata often have lower zinc levels, and more hair loss is linked to even lower zinc levels.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.